Revision of medicine prices and sales price evolution in Moroccan pharmacies.

IF 1 Q4 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
Pan African Medical Journal Pub Date : 2025-06-04 eCollection Date: 2025-01-01 DOI:10.11604/pamj.2025.51.28.45569
Fatima Zahra Bimegdi, Abdelmajid Belaiche, Samir Ahid
{"title":"Revision of medicine prices and sales price evolution in Moroccan pharmacies.","authors":"Fatima Zahra Bimegdi, Abdelmajid Belaiche, Samir Ahid","doi":"10.11604/pamj.2025.51.28.45569","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Morocco adopted a new medicines pricing policy in 2013 that introduced price revisions following the implementation of Decree No. 2-13-852. This study aims to describe the evolution in medicine price decreases in Moroccan pharmacies following the price revisions published by the Ministry of Health.</p><p><strong>Methods: </strong>as part of a retrospective descriptive study, all the price revision lists over five years (2014-2019) were crossed with the databases of sales of medicines sold in pharmacies.</p><p><strong>Results: </strong>price decrease affected 1704 medicines, 54% of which were originator drugs. All therapeutic classes were involved, 22.7% were anti-infective, and 18.5% were for the cardiovascular system. Medicines with a public selling price between 5 and 10 US dollars (25.4%) were the most affected by the drop, even if it has concerned all price ranges. 22.8% of medicines decreased by less than or equal to 0.1 US dollar, and 28.7% recorded decreases of less than or equal to 1% of the public selling price. Five medicines (0.3%) have been reduced by over 70%, with 73.2% as a maximum drop percentage.</p><p><strong>Conclusion: </strong>following the implementation of Decree no. 2-13-852, a series of medicine price revisions was adopted. All price ranges and therapeutic classes were affected by the price decrease, with several variations. However, complementary policies are still needed to improve access to medicines.</p>","PeriodicalId":48190,"journal":{"name":"Pan African Medical Journal","volume":"51 ","pages":"28"},"PeriodicalIF":1.0000,"publicationDate":"2025-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12318877/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pan African Medical Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.11604/pamj.2025.51.28.45569","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Morocco adopted a new medicines pricing policy in 2013 that introduced price revisions following the implementation of Decree No. 2-13-852. This study aims to describe the evolution in medicine price decreases in Moroccan pharmacies following the price revisions published by the Ministry of Health.

Methods: as part of a retrospective descriptive study, all the price revision lists over five years (2014-2019) were crossed with the databases of sales of medicines sold in pharmacies.

Results: price decrease affected 1704 medicines, 54% of which were originator drugs. All therapeutic classes were involved, 22.7% were anti-infective, and 18.5% were for the cardiovascular system. Medicines with a public selling price between 5 and 10 US dollars (25.4%) were the most affected by the drop, even if it has concerned all price ranges. 22.8% of medicines decreased by less than or equal to 0.1 US dollar, and 28.7% recorded decreases of less than or equal to 1% of the public selling price. Five medicines (0.3%) have been reduced by over 70%, with 73.2% as a maximum drop percentage.

Conclusion: following the implementation of Decree no. 2-13-852, a series of medicine price revisions was adopted. All price ranges and therapeutic classes were affected by the price decrease, with several variations. However, complementary policies are still needed to improve access to medicines.

摩洛哥药房药品价格的修订和销售价格的演变。
导言:摩洛哥于2013年通过了一项新的药品定价政策,在第2-13-852号法令实施后进行了价格修订。本研究旨在描述在卫生部公布价格修订后摩洛哥药房药品价格下降的演变情况。方法:作为回顾性描述性研究的一部分,将所有五年内(2014-2019年)的价格修订清单与药店销售的药品销售数据库进行交叉分析。结果:1704种药品价格下降,其中原研药占54%。涉及所有治疗类别,22.7%为抗感染,18.5%为心血管系统。公开售价在5至10美元之间的药物(25.4%)受下降影响最大,即使它涉及所有价格区间。22.8%的药品下降幅度小于或等于0.1美元,28.7%的药品下降幅度小于或等于公开售价的1%。5种药物(0.3%)降幅超过70%,最大降幅为73.2%。结论:在执行第。2-13-852,通过了一系列药品价格修订。所有价格范围和治疗类别都受到价格下降的影响,有几个变化。然而,仍然需要补充政策来改善获得药物的机会。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Pan African Medical Journal
Pan African Medical Journal PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH-
CiteScore
1.80
自引率
0.00%
发文量
691
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信